{"disease":{"id":"glioblastoma-or-gliosarcoma","name":"glioblastoma or gliosarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06954636","title":"Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Sied Kebir","has_results":false},{"nct_id":"NCT00441142","title":"Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Patrick Y. Wen, MD","has_results":true},{"nct_id":"NCT01814813","title":"Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":90,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":true},{"nct_id":"NCT02386826","title":"INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"SCRI Development Innovations, LLC","has_results":false},{"nct_id":"NCT00879437","title":"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT02197169","title":"DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"DNAtrix, Inc.","has_results":false},{"nct_id":"NCT01931098","title":"Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05084430","title":"Study of Pembrolizumab and M032 (NSC 733972)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04991870","title":"Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02709226","title":"Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05052957","title":"hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Leland Metheny","has_results":false},{"nct_id":"NCT00031083","title":"Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT06806228","title":"Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Petrov, Andrey","has_results":false},{"nct_id":"NCT00107003","title":"GW572016 to Treat Recurrent Malignant Brain Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06193174","title":"Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04854044","title":"ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}